mRNA |
THZ-2-102-1 |
GDSC1000 |
pan-cancer |
AAC |
0.14 |
1e-05 |
mRNA |
navitoclax:piperlongumine (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.17 |
1e-05 |
mRNA |
Ispinesib Mesylate |
GDSC1000 |
pan-cancer |
AAC |
0.15 |
1e-05 |
mRNA |
BRD-K49290616 |
CTRPv2 |
pan-cancer |
AAC |
0.36 |
2e-05 |
mRNA |
JQ-1:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.16 |
2e-05 |
mRNA |
NSC95397 |
CTRPv2 |
pan-cancer |
AAC |
0.16 |
2e-05 |
mRNA |
BRD-K34222889 |
CTRPv2 |
pan-cancer |
AAC |
0.15 |
2e-05 |
mRNA |
decitabine:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.15 |
2e-05 |
mRNA |
doxorubicin:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.15 |
2e-05 |
mRNA |
Cetuximab |
GDSC1000 |
pan-cancer |
AAC |
-0.15 |
3e-05 |